Cardio Diagnostics (CDIO) Stock: Buy, Sell, or Hold?
CDIO - Cardio Diagnostics Holdings Inc. Common stock
$2.05
0.07 (3.54%)
▲
5d:
+12.02%
30d:
-5.09%
90d:
+2.5%
BUY
HIGH Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When CDIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CDIO shows strong fundamentals and good volume confirmation. Solid entry point despite extended pricing.
✅ BUY SIGNAL: CDIO shows strong fundamentals and good volume confirmation. Solid entry point despite extended pricing.
In-depth Analysis How we analyze
Valuation Analysis: CDIO is currently trading at $2.05, which is considered extended relative to its 30-day fair value range of $1.77 to $2.04.
Technical Outlook: Technically, CDIO is showing sideways momentum. Immediate support is located at $1.80, while resistance sits at $2.14. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: CDIO scores 72/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $60.00 (+2930.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CDIO is showing sideways momentum. Immediate support is located at $1.80, while resistance sits at $2.14. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: CDIO scores 72/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $60.00 (+2930.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.77 -
$2.04
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
68.4%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (72/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.5%)
- BULLISH: Trading 2930.3% below Wall St target ($60.00)
- BULLISH: Bottoming setup score 72/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$1.77 -
$2.04
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.80
Resistance Level
$2.14
Current Trend
Sideways
Technical data as of
Sep 11, 2026
Fundamental Context
Wall Street Target
$60.00
(+2930.3%)
Revenue Growth (YoY)
-28.3%
Share & Embed Analysis
Last updated: September 11, 2026 3:28 PM ET
Data refreshes hourly during market hours. Next update: 4:28 PM
Data refreshes hourly during market hours. Next update: 4:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CDIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$370 | 43 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$432 | 48 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$570 | 38 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$315 | 47 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
